Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy

被引:20
|
作者
Weinberg, A
Pahwa, S
Oyomopito, R
Carey, VJ
Zimmer, B
Mofenson, L
Kovacs, A
Burchett, SK
机构
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA
[2] N Shore Univ Hosp, Manhasset, NY USA
[3] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[5] Childrens Hosp, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] NICHHD, NIH, Rockville, MD USA
[8] Los Angeles Cty Med Ctr, Los Angeles, CA USA
[9] Univ So Calif, Med Ctr, Los Angeles, CA USA
关键词
D O I
10.1086/420931
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To identify virological and immunological correlates of microbial-specific immune reconstitution in children with advanced human immunodeficiency virus (HIV) infection, Candida- and tetanus-specific lymphocyte proliferation was measured in 165 children initiating a new highly active antiretroviral therapy ( HAART) regimen. During the study, the proportions of children with immunity to Candida and tetanus increased from 53% to 66% and 19% to 22%, respectively. Tetanus immunity was associated with an HIV load less than or equal to400 RNA copies/mL and with Candida immunity. At the end of the study, 23% of the patients with baseline negative lymphocyte proliferation had tetanus immunity, and 65% had Candida immunity. Reconstitution of tetanus immunity correlated with lower end-of-study HIV loads and activated CD8(+) cell percentages and higher baseline and in-study CD4(+) cell percentages, but not with a gain of CD4(+) cells. Reconstitution of Candida immunity showed similar trends. In conclusion, children with advanced HIV infection receiving HAART reconstituted Candida immunity more readily than they did tetanus immunity, suggesting a role for antigen reexposure. Additional factors for immune reconstitution were low HIV load, high CD4(+) cell percentages, and low levels of activated CD8(+) cells.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [1] Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy
    Weinberg, A
    Wohl, DA
    Barrett, RJ
    van der Horst, C
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06): : 707 - 712
  • [2] Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study
    Johnston, AM
    Valentine, ME
    Ottinger, J
    Baydo, R
    Gryszowka, V
    Vavro, C
    Weinhold, K
    Clair, MS
    McKinney, RE
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (10) : 941 - 946
  • [3] Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy
    Pontesilli, O
    Kerkhof-Garde, S
    Notermans, DW
    Foudraine, NA
    Roos, MTL
    Klein, MR
    Danner, SA
    Lange, JMA
    Miedema, F
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01): : 76 - 86
  • [4] Immunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapy
    Weinberg, A
    Pott, GB
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (05) : 821 - 825
  • [5] Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children
    Puthanakit, T
    Oberdorfer, P
    Akarathum, N
    Wannarit, P
    Sirisanthana, T
    Sirisanthana, V
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (01) : 53 - 58
  • [6] Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy
    Nachman, SA
    Lindsey, JC
    Moye, J
    Stanley, KE
    Johnson, GM
    Krogstad, PA
    Wiznia, AA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (04) : 352 - 357
  • [7] Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy
    Weinberg, A
    Wiznia, AA
    LaFleur, BJ
    Shah, S
    Levin, MJ
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (02): : 267 - 270
  • [8] Human papillomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: an immune reconstitution-associated disease?
    Meys, R.
    Gotch, F. M.
    Bunker, C. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (01) : 6 - 11
  • [9] Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: A case of immune reconstitution inflammatory syndrome
    Nuttall, JJC
    Wilmshurst, JM
    Ndondo, AP
    Yeats, J
    Corcoran, C
    Hussey, GD
    Eley, BS
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (07) : 683 - 685
  • [10] Effect of highly active antiretroviral therapy on cardiovascular involvement in children with human immunodeficiency virus infection
    Plebani, A
    Esposito, S
    Pinzani, R
    Fesslova, V
    Bojanin, J
    Salice, P
    Rossi, M
    Principi, N
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) : 559 - 563